Stock Events

Stock Events

Sensorion 

€11.85
56
-€0.22-1.86%Friday 06:01

Statistics

Day High
0
Day Low
0
52W High
11.85
52W Low
0.161
Volume
0
Avg. Volume
235
Mkt Cap
6.11B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Sep 23Expected
Q4 2025
Q2 2026
-2.9
-2.57
-2.23
-1.9
Expected EPS
-1.8962364518999997
Actual EPS
-2.1570943765

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-45.44MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RFM.MU. It's not an investment recommendation.
TotalEnergies
10
TTE.PA
Air Liquide
8
AI.PA
BNP Paribas Easy S&P 500 UCITS Cap EUR
6
ESE.PA
Vallourec
6
VK.PA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Cocrystal Pharma
COCP
Mkt Cap22.06M
Cocrystal Pharma engages in antiviral drug development, including for viruses that can affect hearing, indirectly competing with Sensorion's approach to hearing loss.
Abeona Therapeutics
ABEO
Mkt Cap287.64M
Abeona Therapeutics develops gene and cell therapies for serious diseases, including those affecting hearing, which competes with Sensorion's therapeutic focus.
Biomarin Pharmaceutical
BMRN
Mkt Cap11.07B
BioMarin Pharmaceutical develops and commercializes innovative biopharmaceuticals, some of which may address conditions leading to hearing loss, indirectly competing with Sensorion.

About

Sensorion SA is a clinical-stage biopharmaceutical firm based in Montpellier, France, specializing in the development of therapies for inner ear disorders. Their key initiatives include gene therapy programs: OTOF-GT, designed to restore hearing for individuals with Otoferlin deficiency, and USHER-T1-GT, targeting Usher syndrome Type 1. The company also advances SENS-401, a drug candidate for treating sudden sensorineural hearing loss. Sensorion's broader pipeline encompasses numerous experimental treatments aimed at restoring, treating, and preventing various conditions affecting the inner ear. They hold a collaboration agreement with Institut Pasteur concerning gene therapy for both pediatric and adult deafness. Additionally, Sensorion partners with Sonova Holding AG to integrate genetic analysis into the routine diagnosis of progressive adult hearing loss, combining advanced therapeutic approaches with traditional hearing aids. Founded in 2009, Sensorion SA operates primarily in France.
Show More
CEO
Frédéric Chéreau
Employees
66
Country
France
ISIN
FR0012596468
WKN
000A41Z9F

Listings

PA
FR
ALSEN.PA
STU
DE
RFM.STU
STU
DE
ALSEN.STU
MU
DE
RFM.MU

0 Comments

Share your thoughts

FAQs

What is Sensorion stock price today?▼
The current price of RFM.MU is €11.85 EUR — it has decreased by -1.86% in the past 24 hours. Watch Sensorion stock price performance more closely on the chart.
What is Sensorion stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Sensorion stocks are traded under the ticker RFM.MU.
Is Sensorion stock price growing?▼
RFM.MU stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Sensorion has showed a -30.9% decrease.
What is Sensorion market cap?▼
Today Sensorion has the market capitalization of 6.11B
When is the next Sensorion earnings date?▼
Sensorion is going to release the next earnings report on March 18, 2027.
What were Sensorion earnings last quarter?▼
RFM.MU earnings for the last quarter are -2.16 EUR per share, whereas the estimation was -1.9 EUR resulting in a -13.76% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Sensorion revenue for the last year?▼
Sensorion revenue for the last year amounts to 0 EUR.
What is Sensorion net income for the last year?▼
RFM.MU net income for the last year is -45.44M EUR.
How many employees does Sensorion have?▼
As of November 2, 2026, the company has 66 employees.
In which sector is Sensorion located?▼
Sensorion operates in the Health & Wellness sector.
When did Sensorion complete a stock split?▼
The last stock split for Sensorion was on September 15, 2026 with a ratio of 1:50.
Where is Sensorion headquartered?▼
Sensorion is headquartered in Montpellier, France.